Microbial Cell Banking Market Players Reinvigorate R&D Efforts: Fact.MR Study
Fact. MR. New York: Award-winning market research company Fact.MR has published a report on Microbial Cell Banking Market. As per the report by Fact.MR., due to a rise in demand for microbial cell banking, the global market is projected to register a substantial growth rate over the forecast period 2018-2028. According to the study, market players are relying primarily on R&D that help improvise current models of microbial cell banking to maintain competitiveness. The conventional preservation approach has been replaced by a rise in the use of microbial cell banking. Over the projected timeframe, substantial demand for high-quality biopharmaceuticals is anticipated to fuel demand for microbial cell banking.
According to the report, the development of therapeutics focused on microbial cells has a high potential for addressing unmet medical needs. Increased demand for cell substrates to treat unmet medical needs, on the other hand, has also improved the acceptance of microbial cell banking by end-users. In addition, in the production of cell-based biopharmaceuticals, the regulatory framework has introduced quality requirements. In order to ensure the consistency and safety of biopharmaceuticals, this has led to a growing reliance on microbial cell banking.
Request a report sample with 170 pages to gain comprehensive insights at
- Microbial cell banking's success rate greatly depends on the type of cell medium used according to the specifications. Market players are paying key attention to this.
- The process of maintaining the initial clone or the preliminary cell continues to gain adoption among market participants.
- While functioning cell banks are extracted from the master cell bank, cultural circumstances and components of cell culture vary enormously.
- The market is being fueled by growth in demand for high-quality cell substrates. In addition, the acceptance of microbial cell banking has been boosted by growing concerns about pollution and gene heterogeneity during biopharmaceutical development processes.
- Rapid developments in microbiology have contributed to the integration of disease management with cell substrates/viable cells. The development of therapeutics focused on microbial cells has a high potential for addressing unmet medical needs.
- Increased demand for cell substrates to treat unmet medical needs, on the other hand, has also improved the acceptance of microbial cell banking by end-users.
- The development of the microbial cell banking market is being slowed by growing concerns about contamination and complexity.
Owing to the presence of a significant number of domestic producers, the global microbial cell banking industry is extremely fragmented. Lonza Group Ltd.; Merck KGaA; Biovian Oy; Vibalogics GmbH; Eurofins Scientific; Luina Bio; Altogen Labs; VGXI, Inc.; ATCC; and Charles River Laboratories, Inc. are some of the key players in the market.
The report offers market analysis for North America, Latin America, Europe, Asia-Pacific, excluding Japan (APEJ), Japan, and the Middle East & Africa. Due to rising adoption, US continues to be one of the key markets for microbial cell banking market globally.
In addition to US, UK, France, and Germany are the other key markets for microbial cell banking. Some of the medical tourism hubs in Asia Pacific are also coming up on the map in terms of R&D, according to Fact.MR.
For in-depth Competitive Analysis, Request Customization
More Valuable Insights on Microbial Cell Banking Market
In its latest offering, Fact.MR offers an in-depth study of the global market for microbial cell banking market, showing historical demand estimates (2013-2017) and projected data for the 2018-2028 period. In seven main fields (North America, Latin America, Europe, CIS & Russia, the Asia Pacific Excluding Japan, Japan, the Middle East, and Africa), the study focuses on the type (Working Cell Banking Master Cell Banking) and end-users (Biopharmaceutical Companies, Research Organisations, and Others).
Explore Fact.MR’s Coverage on the Healthcare Domain
Medical Suction Devices Market: In addition to an elevated demand for medical suction devices due to growing hospitalization rates in the COVID-19 pandemic, increasing use for clinical testing and diagnostic purposes has also been noted. The study of Fact.MR indicates that while revenue from wall-mounted suction system sales is higher, mostly because of their high cost, demand for AC-powered devices will grow at a faster pace. The important markets for these products are North America and Europe, with the Asia Pacific medical suction device market now being a lucrative destination for players in this market room.
Medical Gases and Equipment Market: The worldwide demand for medical gases and appliances will continue to see steady growth. Also as the COVID-19 epidemic tightens its noose worldwide, demand is poised to increase. Ventilators will remain a crucial preference for patients needing urgent care before pharmacological therapy is available for COVID-19. Therefore, the industry is faced with the desperate need to ramp up production.
Fact MR's market research includes an in-depth study that covers detailed knowledge on growth factors and constraints. It also gives insights into the trajectory seen in main regional segments.
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates